Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Induction of 70‐point clinical response CDAI · Patients with active Crohn's disease

Low dose naltrexone may leads to higher induction of 70‐point clinical response CDAI compared with placebo (low certainty).

1 finding from 1 review

Low dose naltrexone for induction of remission in Crohn's disease 2018 · Cochrane Headline outcomes only
RR 2.22 [1.14, 4.32]
1 study · 34 participants
Low